InvestorsHub Logo
Followers 0
Posts 219
Boards Moderated 0
Alias Born 07/19/2006

Re: DewDiligence post# 2397

Friday, 11/26/2010 4:49:32 PM

Friday, November 26, 2010 4:49:32 PM

Post# of 2446
So...they are repeatedly trying to take over biotech firms with depressed share prices. It is certainly not because they would have a better understanding of the business or make better managers than the people who have been working away at it for years. What is their general strategy? Presumably it needs to be making a quick buck...so..what...is it the selling off of assets that is key? How does that translate into lining their pockets? Incentive payments to (new) officers upon the sale? A overall stock price that is undervalued relative to the sum of the parts? Does the lack of debt / ability to debt finance going forward play any role that is attractive to them?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News